Capivasertib is an AKT inhibitor designed for HR /HER2breast cancer patients with PIK3CA/AKT1/PTEN alterations. It works by stopping the AKT signal. The drug comes in two strengths: you’ve got 200 mg and 400 mg pills.
You usually take 400 mg twice a day, and you do this for four days in a row, then take three days off. Each bottle holds 64 pills.
